Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Genetic evidence and integration of various data sources for classifying uncertain variants into a single model

Identifieur interne : 008814 ( Main/Exploration ); précédent : 008813; suivant : 008815

Genetic evidence and integration of various data sources for classifying uncertain variants into a single model

Auteurs : David E. Goldgar [États-Unis] ; Douglas F. Easton [Royaume-Uni] ; Graham B. Byrnes [France] ; Amanda B. Spurdle [Australie] ; Edwin S. Iversen [États-Unis] ; Marc S. Greenblatt [États-Unis]

Source :

RBID : ISTEX:398C382D942E916FD69248D4A4929F63D264E709

Descripteurs français

English descriptors

Abstract

Genetic testing often results in the finding of a variant whose clinical significance is unknown. A number of different approaches have been employed in the attempt to classify such variants. For some variants, case‐control, segregation, family history, or other statistical studies can provide strong evidence of direct association with cancer risk. For most variants, other evidence is available that relates to properties of the protein or gene sequence. In this work we propose a Bayesian method for assessing the likelihood that a variant is pathogenic. We discuss the assessment of prior probability, and how to combine the various sources of data into a statistically valid integrated assessment with a posterior probability of pathogenicity. In particular, we propose the use of a two‐component mixture model to integrate these various sources of data and to estimate the parameters related to sensitivity and specificity of specific kinds of evidence. Further, we discuss some of the issues involved in this process and the assumptions that underpin many of the methods used in the evaluation process. Hum Mutat 29(11), 1265–1272, 2008. © 2008 Wiley‐Liss, Inc.

Url:
DOI: 10.1002/humu.20897


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Genetic evidence and integration of various data sources for classifying uncertain variants into a single model</title>
<author>
<name sortKey="Goldgar, David E" sort="Goldgar, David E" uniqKey="Goldgar D" first="David E." last="Goldgar">David E. Goldgar</name>
</author>
<author>
<name sortKey="Easton, Douglas F" sort="Easton, Douglas F" uniqKey="Easton D" first="Douglas F." last="Easton">Douglas F. Easton</name>
</author>
<author>
<name sortKey="Byrnes, Graham B" sort="Byrnes, Graham B" uniqKey="Byrnes G" first="Graham B." last="Byrnes">Graham B. Byrnes</name>
</author>
<author>
<name sortKey="Spurdle, Amanda B" sort="Spurdle, Amanda B" uniqKey="Spurdle A" first="Amanda B." last="Spurdle">Amanda B. Spurdle</name>
</author>
<author>
<name sortKey="Iversen, Edwin S" sort="Iversen, Edwin S" uniqKey="Iversen E" first="Edwin S." last="Iversen">Edwin S. Iversen</name>
</author>
<author>
<name sortKey="Greenblatt, Marc S" sort="Greenblatt, Marc S" uniqKey="Greenblatt M" first="Marc S." last="Greenblatt">Marc S. Greenblatt</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:398C382D942E916FD69248D4A4929F63D264E709</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/humu.20897</idno>
<idno type="url">https://api.istex.fr/document/398C382D942E916FD69248D4A4929F63D264E709/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000A75</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000A75</idno>
<idno type="wicri:Area/Istex/Curation">000A75</idno>
<idno type="wicri:Area/Istex/Checkpoint">001181</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001181</idno>
<idno type="wicri:doubleKey">1059-7794:2008:Goldgar D:genetic:evidence:and</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936773</idno>
<idno type="RBID">PMC:2936773</idno>
<idno type="wicri:Area/Pmc/Corpus">001477</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001477</idno>
<idno type="wicri:Area/Pmc/Curation">001337</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001337</idno>
<idno type="wicri:Area/Pmc/Checkpoint">002A04</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002A04</idno>
<idno type="wicri:Area/Ncbi/Merge">000467</idno>
<idno type="wicri:Area/Ncbi/Curation">000467</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000467</idno>
<idno type="wicri:doubleKey">1059-7794:2008:Goldgar D:genetic:evidence:and</idno>
<idno type="wicri:Area/Main/Merge">009075</idno>
<idno type="wicri:Area/Main/Curation">008814</idno>
<idno type="wicri:Area/Main/Exploration">008814</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Genetic evidence and integration of various data sources for classifying uncertain variants into a single model
<ref type="note" target="#fn1"></ref>
</title>
<author>
<name sortKey="Goldgar, David E" sort="Goldgar, David E" uniqKey="Goldgar D" first="David E." last="Goldgar">David E. Goldgar</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Utah</region>
</placeName>
<wicri:cityArea>Department of Dermatology, University of Utah School of Medicine, Salt Lake City</wicri:cityArea>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">États-Unis</country>
</affiliation>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Utah</region>
</placeName>
<wicri:cityArea>Correspondence address: Department of Dermatology, University of Utah School of Medicine, 30 North 1900 East, SOM A330, Salt Lake City</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Easton, Douglas F" sort="Easton, Douglas F" uniqKey="Easton D" first="Douglas F." last="Easton">Douglas F. Easton</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Genetic Epidemiology Unit, Strangeways Research Laboratories, University of Cambridge, Cambridge</wicri:regionArea>
<orgName type="university">Université de Cambridge</orgName>
<placeName>
<settlement type="city">Cambridge</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Angleterre de l'Est</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Byrnes, Graham B" sort="Byrnes, Graham B" uniqKey="Byrnes G" first="Graham B." last="Byrnes">Graham B. Byrnes</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Epidemiology Methods and Support Group, International Agency for Research on Cancer (IARC), Lyon</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Spurdle, Amanda B" sort="Spurdle, Amanda B" uniqKey="Spurdle A" first="Amanda B." last="Spurdle">Amanda B. Spurdle</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Molecular Cancer Epidemiology Laboratory, Queensland Institute for Medical Research, Brisbane</wicri:regionArea>
<wicri:noRegion>Brisbane</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Iversen, Edwin S" sort="Iversen, Edwin S" uniqKey="Iversen E" first="Edwin S." last="Iversen">Edwin S. Iversen</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Caroline du Nord</region>
</placeName>
<wicri:cityArea>Department of Statistical Science, Duke University, Durham</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Greenblatt, Marc S" sort="Greenblatt, Marc S" uniqKey="Greenblatt M" first="Marc S." last="Greenblatt">Marc S. Greenblatt</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Vermont</region>
</placeName>
<wicri:cityArea>Department of Medicine and Vermont Cancer Center, University of Vermont College of Medicine, Burlington</wicri:cityArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Human Mutation</title>
<title level="j" type="sub">Special Issue: Assessing Mutation Pathogenicity in Cancer Susceptibility Genes</title>
<title level="j" type="alt">HUMAN MUTATION</title>
<idno type="ISSN">1059-7794</idno>
<idno type="eISSN">1098-1004</idno>
<imprint>
<biblScope unit="vol">29</biblScope>
<biblScope unit="issue">11</biblScope>
<biblScope unit="page" from="1265">1265</biblScope>
<biblScope unit="page" to="1272">1272</biblScope>
<biblScope unit="page-count">8</biblScope>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008-11">2008-11</date>
</imprint>
<idno type="ISSN">1059-7794</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1059-7794</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Allele</term>
<term>Allele frequency</term>
<term>Assay</term>
<term>Available data</term>
<term>Brca1</term>
<term>Brca2</term>
<term>Brca2 genes</term>
<term>Breast cancer</term>
<term>Cancer predisposition syndromes</term>
<term>Cancer risk</term>
<term>Causality</term>
<term>Cellular functions</term>
<term>Clinical communities</term>
<term>Clinical observations</term>
<term>Clinical significance</term>
<term>Computational predictions</term>
<term>Cosegregation</term>
<term>Different approaches</term>
<term>Different sources</term>
<term>Disease causality</term>
<term>Disease genes</term>
<term>Disease risk</term>
<term>Early onset</term>
<term>Easton</term>
<term>Family data</term>
<term>Family history</term>
<term>Fanconi anemia</term>
<term>Functional assays</term>
<term>Gene</term>
<term>Genet</term>
<term>Genet evans</term>
<term>Genetic</term>
<term>Genetic counseling</term>
<term>Genetic data</term>
<term>Genetic testing</term>
<term>Genetic variants</term>
<term>Goldgar</term>
<term>Grant number</term>
<term>Hereditary cancer syndromes</term>
<term>Hofstra</term>
<term>Human mutation</term>
<term>Iarc</term>
<term>Indirect evidence</term>
<term>Individual components</term>
<term>International agency</term>
<term>Kconfab investigators</term>
<term>Lake champlain cancer research organization</term>
<term>Large number</term>
<term>Likelihood ratios</term>
<term>Main disadvantage</term>
<term>Medical research</term>
<term>Microsatellite instability</term>
<term>Mismatch repair genes</term>
<term>Missense</term>
<term>Missense mutations</term>
<term>Missense variants</term>
<term>Mixture model</term>
<term>Mlh1</term>
<term>Msh2</term>
<term>Multiple individuals</term>
<term>Mutat</term>
<term>Mutation</term>
<term>National institutes</term>
<term>Neutral variant</term>
<term>Neutral variants</term>
<term>Novel variant</term>
<term>Null hypothesis</term>
<term>Null mutations</term>
<term>Other articles</term>
<term>Other evidence</term>
<term>Other hand</term>
<term>Particular variant</term>
<term>Pathogenic</term>
<term>Pathogenic missense variants</term>
<term>Pathogenic mutation</term>
<term>Pathogenic mutations</term>
<term>Pathogenic variant</term>
<term>Pathogenic variants</term>
<term>Pathogenicity</term>
<term>Penetrance</term>
<term>Penetrance function</term>
<term>Phenotype</term>
<term>Posterior odds</term>
<term>Posterior probability</term>
<term>Quantitative assessment</term>
<term>Queensland institute</term>
<term>Rare variants</term>
<term>Reference groups</term>
<term>Relevant research</term>
<term>Salt lake city</term>
<term>Same gene</term>
<term>Sequence variants</term>
<term>Sequence variation</term>
<term>Such data</term>
<term>Such variants</term>
<term>Syndrome</term>
<term>Systematic studies</term>
<term>Tavtigian</term>
<term>Tumor pathology</term>
<term>Uncertain variants</term>
<term>Unclassified variants</term>
<term>Unknown significance</term>
<term>Utah school</term>
<term>Variant</term>
<term>Various data sources</term>
<term>Various sources</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Allele</term>
<term>Allele frequency</term>
<term>Assay</term>
<term>Available data</term>
<term>Brca1</term>
<term>Brca2</term>
<term>Brca2 genes</term>
<term>Breast cancer</term>
<term>Cancer predisposition syndromes</term>
<term>Cancer risk</term>
<term>Causality</term>
<term>Cellular functions</term>
<term>Clinical communities</term>
<term>Clinical observations</term>
<term>Clinical significance</term>
<term>Computational predictions</term>
<term>Cosegregation</term>
<term>Different approaches</term>
<term>Different sources</term>
<term>Disease causality</term>
<term>Disease genes</term>
<term>Disease risk</term>
<term>Early onset</term>
<term>Easton</term>
<term>Family data</term>
<term>Family history</term>
<term>Fanconi anemia</term>
<term>Functional assays</term>
<term>Gene</term>
<term>Genet</term>
<term>Genet evans</term>
<term>Genetic</term>
<term>Genetic counseling</term>
<term>Genetic data</term>
<term>Genetic testing</term>
<term>Genetic variants</term>
<term>Goldgar</term>
<term>Grant number</term>
<term>Hereditary cancer syndromes</term>
<term>Hofstra</term>
<term>Human mutation</term>
<term>Iarc</term>
<term>Indirect evidence</term>
<term>Individual components</term>
<term>International agency</term>
<term>Kconfab investigators</term>
<term>Lake champlain cancer research organization</term>
<term>Large number</term>
<term>Likelihood ratios</term>
<term>Main disadvantage</term>
<term>Medical research</term>
<term>Microsatellite instability</term>
<term>Mismatch repair genes</term>
<term>Missense</term>
<term>Missense mutations</term>
<term>Missense variants</term>
<term>Mixture model</term>
<term>Mlh1</term>
<term>Msh2</term>
<term>Multiple individuals</term>
<term>Mutat</term>
<term>Mutation</term>
<term>National institutes</term>
<term>Neutral variant</term>
<term>Neutral variants</term>
<term>Novel variant</term>
<term>Null hypothesis</term>
<term>Null mutations</term>
<term>Other articles</term>
<term>Other evidence</term>
<term>Other hand</term>
<term>Particular variant</term>
<term>Pathogenic</term>
<term>Pathogenic missense variants</term>
<term>Pathogenic mutation</term>
<term>Pathogenic mutations</term>
<term>Pathogenic variant</term>
<term>Pathogenic variants</term>
<term>Pathogenicity</term>
<term>Penetrance</term>
<term>Penetrance function</term>
<term>Phenotype</term>
<term>Posterior odds</term>
<term>Posterior probability</term>
<term>Quantitative assessment</term>
<term>Queensland institute</term>
<term>Rare variants</term>
<term>Reference groups</term>
<term>Relevant research</term>
<term>Salt lake city</term>
<term>Same gene</term>
<term>Sequence variants</term>
<term>Sequence variation</term>
<term>Such data</term>
<term>Such variants</term>
<term>Syndrome</term>
<term>Systematic studies</term>
<term>Tavtigian</term>
<term>Tumor pathology</term>
<term>Uncertain variants</term>
<term>Unclassified variants</term>
<term>Unknown significance</term>
<term>Utah school</term>
<term>Variant</term>
<term>Various data sources</term>
<term>Various sources</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Recherche médicale</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Genetic testing often results in the finding of a variant whose clinical significance is unknown. A number of different approaches have been employed in the attempt to classify such variants. For some variants, case‐control, segregation, family history, or other statistical studies can provide strong evidence of direct association with cancer risk. For most variants, other evidence is available that relates to properties of the protein or gene sequence. In this work we propose a Bayesian method for assessing the likelihood that a variant is pathogenic. We discuss the assessment of prior probability, and how to combine the various sources of data into a statistically valid integrated assessment with a posterior probability of pathogenicity. In particular, we propose the use of a two‐component mixture model to integrate these various sources of data and to estimate the parameters related to sensitivity and specificity of specific kinds of evidence. Further, we discuss some of the issues involved in this process and the assumptions that underpin many of the methods used in the evaluation process. Hum Mutat 29(11), 1265–1272, 2008. © 2008 Wiley‐Liss, Inc.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Australie</li>
<li>France</li>
<li>Royaume-Uni</li>
<li>États-Unis</li>
</country>
<region>
<li>Angleterre</li>
<li>Angleterre de l'Est</li>
<li>Auvergne-Rhône-Alpes</li>
<li>Caroline du Nord</li>
<li>Rhône-Alpes</li>
<li>Utah</li>
<li>Vermont</li>
</region>
<settlement>
<li>Cambridge</li>
<li>Lyon</li>
</settlement>
<orgName>
<li>Université de Cambridge</li>
</orgName>
</list>
<tree>
<country name="États-Unis">
<region name="Utah">
<name sortKey="Goldgar, David E" sort="Goldgar, David E" uniqKey="Goldgar D" first="David E." last="Goldgar">David E. Goldgar</name>
</region>
<name sortKey="Goldgar, David E" sort="Goldgar, David E" uniqKey="Goldgar D" first="David E." last="Goldgar">David E. Goldgar</name>
<name sortKey="Goldgar, David E" sort="Goldgar, David E" uniqKey="Goldgar D" first="David E." last="Goldgar">David E. Goldgar</name>
<name sortKey="Greenblatt, Marc S" sort="Greenblatt, Marc S" uniqKey="Greenblatt M" first="Marc S." last="Greenblatt">Marc S. Greenblatt</name>
<name sortKey="Iversen, Edwin S" sort="Iversen, Edwin S" uniqKey="Iversen E" first="Edwin S." last="Iversen">Edwin S. Iversen</name>
</country>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Easton, Douglas F" sort="Easton, Douglas F" uniqKey="Easton D" first="Douglas F." last="Easton">Douglas F. Easton</name>
</region>
</country>
<country name="France">
<region name="Auvergne-Rhône-Alpes">
<name sortKey="Byrnes, Graham B" sort="Byrnes, Graham B" uniqKey="Byrnes G" first="Graham B." last="Byrnes">Graham B. Byrnes</name>
</region>
</country>
<country name="Australie">
<noRegion>
<name sortKey="Spurdle, Amanda B" sort="Spurdle, Amanda B" uniqKey="Spurdle A" first="Amanda B." last="Spurdle">Amanda B. Spurdle</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 008814 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 008814 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:398C382D942E916FD69248D4A4929F63D264E709
   |texte=   Genetic evidence and integration of various data sources for classifying uncertain variants into a single model
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024